Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
European Journal of Clinical Pharmacology
|
November 11, 2011
Placebo-controlled study of the effects of fingolimod on cardiac rate and rhythm and pulmonary function in healthy volunteers
Robert Schmouder, Sam Hariry, Olivier J David
Clinical Drug Investigation
|
February 23, 2017
Can Disproportionality Analysis of Post-marketing Case Reports be Used for Comparison of Drug Safety Profiles?
Christiane Michel, Emil Scosyrev, Michael Petrin, et al.
Clinical Pharmacology in Drug Development
|
April 29, 2016
Tolerability and Pulmonary Pharmacodynamic Effects During Treatment Initiation of Once-Daily Oral Fingolimod in Subjects With Moderate Asthma
Craig Boulton, Olivier J David, Karin Meiser, et al.
Journal of Clinical Pharmacology
|
December 17, 2011
Pharmacodynamic effects of steady-state fingolimod on antibody response in healthy volunteers: a 4-week, randomized, placebo-controlled, parallel-group, multiple-dose study
Craig Boulton, Karin Meiser, Olivier J David, et al.
British Journal of Clinical Pharmacology
|
April 20, 2004
Single-dose FTY720 pharmacokinetics, food effect, and pharmacological responses in healthy subjects
John M Kovarik, Robert Schmouder, Denise Barilla, et al.
Nature Biotechnology
|
May 12, 2010
Next-generation biomarkers for detecting kidney toxicity
Joseph V Bonventre, Vishal S Vaidya, Robert Schmouder, et al.
Clinical Transplantation
|
July 9, 2002
Administration diluents differentiate Neoral from a generic cyclosporine oral solution
John M Kovarik, Denise Barilla, Louis McMahon, et al.
British Journal of Pharmacology
|
February 17, 2026
Randomised, phase 1 evaluation of the safety, tolerability, pharmacokinetics and pharmacodynamics of iptacopan in healthy volunteers
Irina Baltcheva, Guido Junge, Kenneth Kulmatycki, et al.
Journal of Clinical Pharmacology
|
April 23, 2004
Multiple-dose FTY720: tolerability, pharmacokinetics, and lymphocyte responses in healthy subjects
John M Kovarik, Robert Schmouder, Denise Barilla, et al.
Clinical Pharmacology in Drug Development
|
April 26, 2018
Pharmacokinetic Interaction Between Fingolimod and Carbamazepine in Healthy Subjects
Olivier J David, Rhett Behrje, Parasar Pal, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
European Journal of Clinical Pharmacology
|
November 11, 2011
Placebo-controlled study of the effects of fingolimod on cardiac rate and rhythm and pulmonary function in healthy volunteers
Robert Schmouder, Sam Hariry, Olivier J David
Clinical Drug Investigation
|
February 23, 2017
Can Disproportionality Analysis of Post-marketing Case Reports be Used for Comparison of Drug Safety Profiles?
Christiane Michel, Emil Scosyrev, Michael Petrin, et al.
Clinical Pharmacology in Drug Development
|
April 29, 2016
Tolerability and Pulmonary Pharmacodynamic Effects During Treatment Initiation of Once-Daily Oral Fingolimod in Subjects With Moderate Asthma
Craig Boulton, Olivier J David, Karin Meiser, et al.
Journal of Clinical Pharmacology
|
December 17, 2011
Pharmacodynamic effects of steady-state fingolimod on antibody response in healthy volunteers: a 4-week, randomized, placebo-controlled, parallel-group, multiple-dose study
Craig Boulton, Karin Meiser, Olivier J David, et al.
British Journal of Clinical Pharmacology
|
April 20, 2004
Single-dose FTY720 pharmacokinetics, food effect, and pharmacological responses in healthy subjects
John M Kovarik, Robert Schmouder, Denise Barilla, et al.
Nature Biotechnology
|
May 12, 2010
Next-generation biomarkers for detecting kidney toxicity
Joseph V Bonventre, Vishal S Vaidya, Robert Schmouder, et al.
Clinical Transplantation
|
July 9, 2002
Administration diluents differentiate Neoral from a generic cyclosporine oral solution
John M Kovarik, Denise Barilla, Louis McMahon, et al.
British Journal of Pharmacology
|
February 17, 2026
Randomised, phase 1 evaluation of the safety, tolerability, pharmacokinetics and pharmacodynamics of iptacopan in healthy volunteers
Irina Baltcheva, Guido Junge, Kenneth Kulmatycki, et al.
Journal of Clinical Pharmacology
|
April 23, 2004
Multiple-dose FTY720: tolerability, pharmacokinetics, and lymphocyte responses in healthy subjects
John M Kovarik, Robert Schmouder, Denise Barilla, et al.
Clinical Pharmacology in Drug Development
|
April 26, 2018
Pharmacokinetic Interaction Between Fingolimod and Carbamazepine in Healthy Subjects
Olivier J David, Rhett Behrje, Parasar Pal, et al.
Page
of 3